1,371
Views
49
CrossRef citations to date
0
Altmetric
Review

HIV integrase inhibitors: a new era in the treatment of HIV

, MD PhD, , MD, , MD PhD & , MD PhD
Pages 1313-1324 | Published online: 22 May 2015
 

Abstract

Introduction: Integrase inhibitors (INIs) are the latest class of antiretroviral drugs approved for the treatment of HIV infection and are becoming ‘standard’ drugs in the treatment of both naïve as well as heavily pretreated individuals with HIV.

Areas covered: Data on efficacy, safety, tolerability, pharmacokinetics, drug-drug interactions and resistance are reviewed from the pivotal Phase III clinical trials published in PubMed high-impact medical journals or presented at international meetings.

Expert opinion: Due to their outstanding data of efficacy, tolerability, safety – shared by all three drugs (raltegravir, elvitegravir, dolutegravir) currently belonging to this new family of antiretrovirals – INIs have become part of the recommended initial antiretroviral therapy options. Some differences in dosing, drug-drug interactions and robustness/genetic barrier among the three drugs will provide the physician the characteristics to make the best choice.

Acknowledgments

In memory of Iñaki Perez, a great colleague and friend who died recently.

Declaration of interest

JL Blanco Arevalo has received research funding, consultancy, fees, travel expenses or lecture sponsorships from Abbott, Bristol-Myers Squibb, Gilead Sciences, Janssen-Cilag, Merck Sharp and Dohme, and ViiV Healthcare. GG Whitlock has received travel expenses from Janssen-Cilag and ViiV Healthcare. A Milinkovic has nothing to declare. G Moyle received research funding, advisory board and/or speaker fees from Astellas, Astra-Zeneca, Bristol-Myers Squibb, GlaxoSmithKline, Gilead Sciences, Merck Sharp and Dohme, Pfizer, Tobira and ViiV Healthcare.

Notes

This box summarises key points contained in the article.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 99.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 884.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.